CytomX Therapeutics, Inc.

Develops tumor-activated antibody therapeutics for more targeted, less toxic cancer treatments.

CTMX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 151 OYSTER POINT BLVD., 94080 SOUTH SAN FRANCISCO
Website:: https://cytomx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company dedicated to developing a novel class of investigational antibody therapeutics. The company's core technology is its proprietary Probody® platform, which is designed to create conditionally activated biologics. These therapeutics remain masked and inactive in healthy tissue but are activated specifically within the tumor microenvironment. This approach aims to enhance the therapeutic window, enabling more potent and targeted anti-cancer treatments with potentially reduced toxicity. CytomX is advancing a deep pipeline of Probody therapeutics, both independently and through strategic collaborations, to bring new treatment options to cancer patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CytomX Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CytomX Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CytomX Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AVADEL PHARMACEUTICALS PLC Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.	United States of America	AVDL
Avidity Biosciences, Inc. Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.	United States of America	RNA
Axsome Therapeutics, Inc. Biopharma company developing novel therapies for central nervous system (CNS) conditions.	United States of America	AXSM
AYTU BIOPHARMA, INC Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.	United States of America	AYTU
Azitra, Inc. Developing engineered proteins and live biotherapeutics for rare skin diseases.	United States of America	AZTR
Bachem Holding AG A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.	Switzerland	BANB
Barinthus Biotherapeutics plc. Develops T cell immunotherapies for autoimmune and chronic infectious diseases.	United States of America	BRNS
Basilea Pharmaceutica AG Develops & commercializes anti-infectives for severe bacterial & fungal infections.	Switzerland	BSLN
Bausch Health Companies Inc. Develops, manufactures, and markets pharmaceuticals, OTCs, and medical devices globally.	United States of America	BHC
Bavarian Nordic A biotech firm developing and manufacturing life-saving vaccines for travel and public health.	Denmark	BAVA